Summer is normally supposed to be the quiet part of the year. Not in the stock market of 2026.
Artificial intelligence spending continues to reshape the technology sector, pharmaceutical companies are generating enormous growth from new treatments, and some of the world’s largest financial groups are entering the second half of the year from positions of remarkable strength.
That does not mean every rising stock is automatically a good investment. Some of the most popular companies already carry demanding valuations, while geopolitical tensions, interest rates and an unexpected slowdown in economic growth could quickly change market sentiment.
But looking at recent earnings, growth prospects and the catalysts ahead, five companies stand out as particularly interesting names to watch during the rest of summer 2026: Alphabet, Microsoft, Nvidia, Eli Lilly and JPMorgan Chase.
This is not a list of guaranteed winners. It is a selection of companies whose businesses currently offer particularly interesting opportunities—and whose risks investors should understand before buying.
Contents
1. Alphabet: Perhaps the Most Interesting Big Tech Value
Alphabet may be the most surprising name on this list.
Google already dominates global search, owns YouTube and operates one of the world’s largest advertising businesses. What is changing the investment story in 2026, however, is Google Cloud and artificial intelligence.
Alphabet reported second-quarter revenue growth of 24% year over year, reaching $119.8 billion. Even more striking was Google Cloud, where revenue jumped 82% to $24.8 billion, while the division’s backlog climbed to approximately $514 billion.
Those numbers matter because they suggest AI is not simply creating enormous expenses for Google. It is increasingly becoming a source of revenue across cloud infrastructure, enterprise products and the company’s core businesses.
Google’s traditional engine also remains powerful. Search and Other advertising revenue increased 17% in the quarter, while YouTube advertising grew 13%.
That creates an attractive combination: a mature cash-generating technology giant that is also participating directly in one of the fastest-growing areas of the global economy.
The risk is equally clear. Alphabet is spending extraordinary amounts on AI infrastructure, with full-year capital expenditure now expected to reach roughly $195 billion to $205 billion. Competition in AI search is also becoming much more intense, meaning Google still has to prove that its enormous investment will generate sustainable returns.
2. Microsoft: The More Diversified Way to Bet on AI
If Alphabet looks attractive because of the acceleration in its cloud business, Microsoft stands out because of consistency and diversification.
The company is no longer simply Windows and Office. Azure, Microsoft 365, cybersecurity, GitHub and AI services have transformed Microsoft into one of the world’s most important enterprise technology platforms.
Its latest results reinforce that position. Microsoft generated $90 billion in quarterly revenue, up 18% year over year, while Microsoft Cloud revenue reached $59.3 billion, increasing 27%.
Perhaps even more interesting is the amount of contracted business waiting to become revenue. Microsoft’s commercial remaining performance obligation reached $678 billion, up 84% from a year earlier.
That backlog gives investors something particularly valuable: visibility.
AI is being integrated across Azure, Microsoft 365 Copilot, GitHub and the company’s wider enterprise ecosystem. Microsoft therefore does not need one standalone AI product to succeed. It can monetize the technology across services businesses already use every day.
The downside is that quality has a price. Microsoft remains a highly valued company, and satisfying growing demand for AI computing capacity requires huge investments in data centers and infrastructure.
Still, for investors looking for exposure to artificial intelligence without relying entirely on a single chip, application or consumer product, Microsoft remains one of the strongest all-round businesses in the sector.
3. Nvidia: Incredible Growth, but the Biggest Test Is Coming
No company represents the AI investment boom better than Nvidia.
The numbers remain extraordinary. In its latest reported quarter, Nvidia generated $81.6 billion in revenue, up 85% from a year earlier. Data Center revenue alone reached $75.2 billion, an increase of 92%.
The reason is simple: companies building modern AI systems still need enormous amounts of computing power, and Nvidia remains at the center of that infrastructure.
But Nvidia is also the stock on this list that deserves particularly close attention during August.
The company is scheduled to publish its next quarterly results on August 26, 2026. Expectations are already extremely high, meaning even excellent numbers may disappoint the market if growth or guidance falls short of what investors have priced into the shares.
That makes Nvidia both one of summer 2026’s most compelling opportunities and one of the clearest examples of the difference between a fantastic company and a risk-free investment.
4. Eli Lilly: Healthcare Growth Is Becoming Hard to Ignore
Technology is not the only place where investors are finding extraordinary growth in 2026.
Eli Lilly has become one of the most closely watched companies in the healthcare sector, driven largely by explosive demand for its diabetes and weight-loss treatments Mounjaro and Zepbound.
The latest numbers are difficult to ignore. Lilly’s second-quarter revenue increased 48% year over year to almost $23 billion, while net income reached $7.1 billion. The company subsequently raised its full-year revenue forecast to between $85 billion and $87 billion.
And the investment story goes beyond its current blockbuster drugs. Lilly is spending heavily on manufacturing capacity while developing another generation of treatments, including retatrutide, which has produced encouraging late-stage results in obesity studies.
The risk is valuation. Investors already expect years of exceptional growth, meaning disappointing clinical results, stronger competition or pressure on drug pricing could quickly affect the stock. But if demand for obesity and diabetes treatments continues expanding globally, Lilly remains one of the most powerful growth stories outside Big Tech.
5. JPMorgan Chase: A Different Kind of Opportunity
JPMorgan Chase offers something completely different from the first four stocks.
Instead of depending on AI or a new pharmaceutical breakthrough, the largest U.S. bank benefits from an enormous and highly diversified financial business spanning consumer banking, investment banking, payments, asset management and global markets.
Its second-quarter results showed that strength clearly. Excluding significant items, JPMorgan generated approximately $16.9 billion in net income, while managed revenue reached around $58 billion.
For investors worried that technology valuations have become too stretched, JPMorgan can provide exposure to a completely different part of the economy. Strong capital generation, scale and diversification have helped the bank remain highly profitable through very different interest-rate environments.
The risks are more traditional: an economic slowdown, rising credit losses, weaker dealmaking or sharp changes in interest rates could hurt earnings. But among major financial stocks, JPMorgan remains one of the strongest businesses to watch during the second half of 2026.
Which of These Five Stocks Looks Most Interesting?
There is no single answer because the five companies offer very different combinations of risk and potential return.
Alphabet may offer one of the most interesting combinations of established profitability and accelerating AI growth. Microsoft provides perhaps the broadest and most diversified exposure to enterprise AI. Nvidia offers exceptional growth but also carries enormous expectations. Eli Lilly gives investors exposure to a healthcare market undergoing a major transformation, while JPMorgan provides a more traditional alternative to technology-heavy portfolios.
That distinction matters. Buying five famous companies is not automatically the same as building a diversified portfolio, particularly when three of the five are heavily exposed to the same AI investment cycle.
Why Investors Still Need to Be Careful This Summer
Strong companies can still become poor investments when purchased at the wrong price.
That has already been one of the major lessons of 2026. Some of the world’s largest technology companies have experienced sharp corrections even while continuing to generate enormous profits, because markets had already priced in extremely optimistic expectations.
If you want to understand why that can happen, our analysis of why the Big Tech stocks everyone knows can suddenly fall explains how AI expectations, valuations, interest rates and profit-taking can hit even excellent companies.
Currency movements matter too, particularly for European investors buying U.S.-listed shares. A stock can rise in dollars while changes in the exchange rate alter the return received in euros. Our guide to the euro versus the dollar in 2026 explains why exchange rates can become an important part of an international investment decision.
Alphabet, Microsoft, Nvidia, Eli Lilly and JPMorgan therefore deserve attention this summer, but none should be treated as guaranteed winners. Earnings, valuation, portfolio diversification and individual risk tolerance still matter more than any headline about the “best” stock to buy.
Before investing, readers can also consult Investor.gov’s official guide to investing, which explains investment risk, diversification and the importance of matching investments to personal financial goals and time horizons.
